The potential benefits of using computed tomography (CT) colonography to screen asymptomatic adults aged 50 to 80 years for colorectal cancer outweigh the risks, according to most of the 24 members of ...
SEATTLE, Oct. 31, 2019 /PRNewswire/ -- RareCyte announces an addition to the RarePlex ® Staining Kit product line, enabling customers to evaluate HER2 and ER expression on circulating tumor cells ...
SEATTLE, Oct. 29, 2019 /PRNewswire/ -- RareCyte announces the launch of the of RarePlex ® Developer Kits that uniquely enable customers to add their own biomarkers to RareCyte circulating tumor cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback